You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 29, 2024

Details for New Drug Application (NDA): 090463


✉ Email this page to a colleague

« Back to Dashboard


NDA 090463 describes PERINDOPRIL ERBUMINE, which is a drug marketed by Ani Pharms, Apotex, Aurobindo Pharma, Hikma, and Lupin Ltd, and is included in five NDAs. It is available from one supplier. Additional details are available on the PERINDOPRIL ERBUMINE profile page.

The generic ingredient in PERINDOPRIL ERBUMINE is perindopril erbumine. There are fourteen drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the perindopril erbumine profile page.
Summary for 090463
Tradename:PERINDOPRIL ERBUMINE
Applicant:Apotex
Ingredient:perindopril erbumine
Patents:0
Medical Subject Heading (MeSH) Categories for 090463

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:TABLET;ORALStrength2MG
Approval Date:Aug 30, 2010TE:RLD:No

Profile for product number 002

Active Rx/OTC/Discontinued:DISCNDosage:TABLET;ORALStrength4MG
Approval Date:Aug 30, 2010TE:RLD:No

Profile for product number 003

Active Rx/OTC/Discontinued:DISCNDosage:TABLET;ORALStrength8MG
Approval Date:Aug 30, 2010TE:RLD:No

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.